Estimating the key outcomes and hepatocellular carcinoma risk in patients in immune‐tolerant phase of chronic hepatitis B virus infection: A systematic review and meta‐analysis

Documenti analoghi

• Risk predictive model for the development of hepatocellular carcinoma before initiating long‐term antiviral therapy in patients with chronic hepatitis B virus infection
  di: Junjie Chen, et al.
  Pubblicazione: (2024)
• Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patients
  di: Mathias Schemmerer, et al.
  Pubblicazione: (2024)
• Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
  di: Yuanjie Liu, et al.
  Pubblicazione: (2024)
• Diagnostic performance of dried blood spot hepatitis C virus core antigen testing for hepatitis C screening: A systematic review and meta‐analysis
  di: Ana Treviño‐Nakoura, et al.
  Pubblicazione: (2024)
• Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation
  di: Ping He, et al.
  Pubblicazione: (2024)